Roberta Torregrossa
St. Luke's Campus
Exeter, ENG EX12LU, United Kingdom
Exeter, ENG EX12LU, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Corrigendum to "Neuroprotection by post-stroke administration of the slow-releasing hydrogen sulfide (H2S) donor AP39: Long-term functional, MRI, and molecular evidence in a rodent stroke model" [European J. Pharmacol. 1008 (2025) 178331].
Journal: European journal of pharmacology
Published: June 13, 2026
The mitochondria-targeted hydrogen sulfide donor AP39 reduces cortical stroke volume and improves motor function in a photothrombotic stroke model in mice in a sex-dependent manner.
Journal: Neuropharmacology
Published: January 07, 2025
AP39, a novel mitochondria-targeted hydrogen sulfide donor, promotes cutaneous wound healing in an in vivo murine model of acute frostbite injury.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 18, 2024
Mitochondria-targeted hydrogen sulfide donor reduces atherogenesis by changing macrophage phenotypes and increasing UCP1 expression in vascular smooth muscle cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 25, 2024
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways.
Journal: Pharmacological research
Published: May 08, 2024
Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated Caenorhabditis elegans.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 31, 2023
The mitochondria-targeted sulfide delivery molecule attenuates drugs-induced gastropathy. Involvement of heme oxygenase pathway.
Journal: Redox biology
Published: July 14, 2023
Hydrogen sulfide donor AP123 restores endothelial nitric oxide-dependent vascular function in hyperglycemia via a CREB-dependent pathway.
Journal: Redox biology
Published: February 27, 2023
Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of H2S lead to H2S deficiency in calcific aortic valve disease.
Journal: Redox biology
Published: January 16, 2023
Mitochondrial H2S donor AP39 induces stomatal closure by modulating guard cell mitochondrial activity.
Journal: Plant physiology
Published: September 29, 2022
Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 17, 2022
Last Updated: 09/26/2026